BASILEA PHARMACEUBASILEA PHARMACEUBASILEA PHARMACEU

BASILEA PHARMACEU

No trades
See on Supercharts

PK5 fundamentals

BASILEA PHARMACEU financial statements, including revenue, expenses, profit, and loss

The total revenue of PK5 for the last semiannual is 76.29 M CHF, and it's 4.90% higher compared to the previous semiannual. The net income of H1 24 is 20.74 M CHF.

Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth